Prevalence of anxiety, depression, and post-traumatic stress disorder during the COVID-19 lockdown in patients with rheumatoid arthritis or systemic lupus erythematosus: a systematic review.

Publication date: May 26, 2025

The COVID-19 pandemic and its associated lockdown measures had a profound impact on mental health, particularly among individuals with chronic illnesses. Patients with autoimmune arthritis, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), are already at increased risk for psychological disorders due to the chronic nature of their disease, physical disability, and long-term medication use. The added stress of the pandemic, including fear of infection, limited access to healthcare, and social isolation, may have further exacerbated mental health issues in this population. This systematic review aims to evaluate the prevalence of anxiety, depression, and post-traumatic stress disorder (PTSD) among individuals with autoimmune arthritis during the pandemic. A comprehensive search of major medical databases identified 18 relevant studies, encompassing 9,666 participants from various geographic regions. By synthesizing findings across diverse populations, this review examines the extent of the mental health burden in this vulnerable group and highlights the importance of mental health support during public health crises. Understanding these impacts can help guide future research and inform healthcare policies to better support autoimmune arthritis patients in times of crisis.

Open Access PDF

Concepts Keywords
Covid Anxiety
Databases Arthritis, Rheumatoid
Increased Autoimmune arthritis
Pandemic COVID-19
Psychiatry COVID-19
Depression
Depression
Humans
Lockdown
Lupus Erythematosus, Systemic
Prevalence
PTSD
Stress Disorders, Post-Traumatic

Semantics

Type Source Name
disease MESH anxiety
disease MESH depression
disease MESH post-traumatic stress disorder
disease MESH COVID-19
disease MESH rheumatoid arthritis
pathway KEGG Rheumatoid arthritis
disease MESH systemic lupus erythematosus
pathway KEGG Systemic lupus erythematosus
disease MESH chronic illnesses
disease MESH arthritis
disease MESH infection
drug DRUGBANK Tropicamide
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH Malignancy
disease MESH Autoimmunity
disease MESH emergency
disease MESH death
disease MESH loneliness
disease MESH lifestyle
disease MESH autoimmune diseases
disease MESH bipolar disorder
drug DRUGBANK Cysteamine
drug DRUGBANK Ranitidine
disease MESH psoriatic arthritis
disease MESH ankylosing spondylitis
disease MESH fibromyalgia
disease MESH mental disorders
disease MESH depressive disorders
disease MESH eating disorders
disease IDO process
disease MESH juvenile idiopathic arthritis
disease IDO symptom
disease MESH Anxiety Disorder
drug DRUGBANK Indoleacetic acid
disease MESH traumatic stress disorders
drug DRUGBANK Esomeprazole

Original Article

(Visited 1 times, 1 visits today)